Katri Lindfors

Activities

Activities per year 2003 2009 2010 2011 2012 2013 2019 2022

• 172 Conference presentation
• 29 Reviewer of Scientific Journal
• 14 Supervisor of master student
• 7 Supervisor of doctoral candidate
• 41 More
  • 7 Invited lecture
  • 6 Pre-examination of dissertation or acting as opponent to doctoral students
  • 5 Regular membership of a society or network
  • 5 Position of trust in a funding organization
  • 4 Media appearance
  • 3 Supervisor of licentiate candidate in medicine
  • 2 Chair of workshop, panel, session or tutorial
  • 2 Membership of an organizing committee of a conference or seminar
  • 2 Public talk
  • 1 Membership of a scientific or program committee of a conference or seminar
  • 1 Consultancy
  • 1 Position of trust in a society or network
  • 1 Academic qualification (e.g. title of docent)
  • 1 Leadership of a scientific program or project

Activities per year

Search results

• Suomen Keliakialiitto (External organisation)

  Katri Lindfors (Member)

  1 Mar 2013 → 31 Dec 2016

  Activity: Membership › Regular membership of a society or network

• The expression of epithelial junction proteins is decreased in early developing coeliac disease and negatively correlates with diarrhoea

  Tiina Rauhavirta (Contributor), Pekka Collin (Contributor), Katri Kaukinen (Contributor), Kaija Laurila (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• Celiac disease–specific TG2-targeted autoantibodies inhibit angiogenesis in vivo in mice by modulating extracellular matrix

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Ana-Marija Sulic (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Markku Mäki (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor) & Katri Lindfors (Contributor)

  14 Feb 2013

  Activity: Talk or presentation › Conference presentation

• Mucosal Immunology (Journal)

  Katri Lindfors (Reviewer)

  2013

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Opinnäytetöiden ohjaus, Pro gradu -tutkielma: Ohutsuolen epiteelin erilaistuminen ja kantasolujen käyttö keliakiatutkimuksessa

  Katri Lindfors (Examiner)

  2013 → 2014

  Activity: Evaluation, examination and supervision › Supervisor of master student

• Clinical Immunology (Journal)

  Katri Lindfors (Reviewer)

  2013

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Opinnäytetöiden ohjaus, Pro gradu -tutkielma: Characterization of serological targets and cellular alterations in the small bowel mucosa in non-coeliac gluten sensitivity

  Katri Lindfors (Examiner)

  2013 → 2014

  Activity: Evaluation, examination and supervision › Supervisor of master student

• PlosOne (Journal)

  Katri Lindfors (Reviewer)

  2013

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Journal of Cellular and Molecular Medicine (Journal)

  Katri Lindfors (Reviewer)

  2013

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• The expression of epithelial junction proteins is decreased already in early developing coeliac disease and negatively correlates with diarrhoea

  Tiina Rauhavirta (Contributor), Katri Lindfors (Contributor), Kaija Laurila (Contributor), Markku Mäki (Contributor), Pekka Collin (Contributor) & Katri Kaukinen (Contributor)

  18 Dec 2012

  Activity: Talk or presentation › Conference presentation

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Emily McKinney (Contributor), Sergio Caja Galan (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  18 Dec 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  18 Dec 2012

  Activity: Talk or presentation › Conference presentation

• Association study of FUT2 (rs601338) with celiac disease and inflammatory bowel disease in the Finnish population

  Amarjit Singh Parmar (Contributor), Noora Alakulppi (Contributor), Paulina Paavola-Sakki (Contributor), Kalle Kurppa (Contributor), Leena Halme (Contributor), Martti Färkkilä (Contributor), Ulla Turunen (Contributor), Maarit Lappalainen (Contributor), Kimmo Kontula (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor), Katri Lindfors (Contributor), Jukka Partanen (Contributor), Pertti Sistonen (Contributor), Jaana Mättö (Contributor), Pirjo Wacklin (Contributor), Päivi Saavalainen (Contributor) & Elisabet Einarsdottir (Contributor)

  17 Sept 2012

  Activity: Talk or presentation › Conference presentation

• A new method for culturing intestinal biopsies derived from coeliac disease patients using a mouse model

  Emily McKinney (Contributor), Boglarka Toth (Contributor), Markku Maki (Contributor), Katri Lindfors (Contributor), Ilma Korponay-Szabo (Contributor) & Sergio Caja (Contributor)

  8 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo through RhoB

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Cristina Nadalutti (Contributor), Tiina Rauhavirta (Contributor) & Ana-Marija Sulic (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Celiac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo through RhoB

  Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor), Cristina Nadalutti (Contributor) & Tiina Rauhavirta (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Biological effects of celiac IgA

  Katri Lindfors (Keynote speaker)

  7 Sept 2012

  Activity: Talk or presentation › Invited lecture

• The duodenal microbiota composition of adult coeliac disease patients differs between various disease outcomes

  Pirjo Wacklin (Contributor), Katri Kaukinen (Contributor), Elina Tuovinen (Contributor), Pekka Collin (Contributor), Katri Lindfors (Contributor), Jukka Partanen (Contributor), Markku Mäki (Contributor) & Jaana Mättö (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• Transglutaminase 2 and thioredoxin : current research in celiac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Markku Mäki (Contributor), Russell Collighan (Contributor), Martin Griffin (Contributor) & Katri Lindfors (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity – implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Mikko Oittinen (Contributor)

  7 Sept 2012

  Activity: Talk or presentation › Conference presentation

• International Coeliac Disease Scientific Conference; Better Life for Coeliacs

  Katri Lindfors (Organiser)

  6 Sept 2012 → 9 Sept 2012

  Activity: Participating in or organising an event › Membership of an organizing committee of a conference or seminar

• Biological effects of celiac disease antibodies

  Katri Lindfors (Keynote speaker)

  16 Jul 2012

  Activity: Talk or presentation › Invited lecture

• Transglutaminase 2 and thioredoxin: current research in celiac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  16 Jul 2012

  Activity: Talk or presentation › Conference presentation

• Injection of celiac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing celiac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma R. Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  16 Jul 2012

  Activity: Talk or presentation › Conference presentation

• Association of FUT2 (rs601338) with celiac disease in Finnish patients

  A Parmar (Contributor), N Alakulppi (Contributor), E Einarsdottir (Contributor), K Kaukinen (Contributor), K Kurppa (Contributor), M Mäki (Contributor), K Lindfors (Contributor), J Partanen (Contributor), K Aranko (Contributor), J Mättö (Contributor), P Wacklin (Contributor) & P Saavalainen (Contributor)

  25 Jun 2012

  Activity: Talk or presentation › Conference presentation

• Association of FUT2 (RS601338) with celiac disease in the Finnish population

  Katri Lindfors (Contributor), Katri Kaukinen (Contributor), Kalle Kurppa (Contributor) & Markku Mäki (Contributor)

  7 Jun 2012

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity - implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Mikko Oittinen (Contributor)

  7 Jun 2012

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Johanna Schleutker (Contributor), Päivi Saavalainen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  7 Jun 2012

  Activity: Talk or presentation › Conference presentation

• Passive transfer of celiac patient serum or purified serum immunoglobulins induce features of early developing celiac disease in mice

  Katri Lindfors (Speaker), Sergio Caja Galan (Speaker), Suvi Kalliokoski (Speaker), Katri Kaukinen (Speaker), Ilma Korponay-Szabó (Speaker) & Markku Mäki (Speaker)

  11 May 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja (Contributor), Ilma Korponay-Szabó (Contributor), Rafael Frias (Contributor), Outi Koskinen (Contributor), Markku Mäki (Contributor), Katri Kaukinen (Contributor) & Katri Lindfors (Contributor)

  27 Apr 2012

  Activity: Talk or presentation › Conference presentation

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Speaker), Sergio Caja (Speaker), Ilma R. Korponay-Szabó (Speaker), Rafael Frias (Speaker), Outi Koskinen (Speaker), Markku Mäki (Speaker), Katri Kaukinen (Speaker) & Katri Lindfors (Speaker)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• Genetic background of coeliac disease - chemokine receptor CCR9 and its ligand CCL25

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• Transglutaminase 2 and thioredoxin : current research in celiac disease

  Cristina Nadalutti (Contributor), Katri Kaukinen (Contributor), Martin Griffin (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity - implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor), Markku Mäki (Contributor) & Mikko Oittinen (Contributor)

  9 Feb 2012

  Activity: Talk or presentation › Conference presentation

• Pharmaceutical Research (Journal)

  Katri Lindfors (Reviewer)

  2012

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Fondazione Cariplo (External organisation)

  Katri Lindfors (Reviewer)

  2012

  Activity: Membership › Position of trust in a funding organization

• BMC Immunology (Journal)

  Katri Lindfors (Reviewer)

  2012

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• BBA - General subjects (Journal)

  Katri Lindfors (Reviewer)

  2012

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Expert opinion on Drug Discovery (Journal)

  Katri Lindfors (Reviewer)

  2012

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Opinnäytetöiden ohjaus, Väitöskirja: The Effects of transglutaminase 2 modulation on endothelial cell biology - focus on celiac disease pathogenesis

  Katri Lindfors (Examiner)

  2012 → 2013

  Activity: Evaluation, examination and supervision › Supervisor of doctoral candidate

• Hum Immunol (Journal)

  Katri Lindfors (Reviewer)

  2012

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Opinnäytetöiden ohjaus, Pro gradu -tutkielma: Effects of coeliac patient anti-transglutaminase 2 autoantibodies on the enzymatic activity of transglutaminase 2 in intestinal epithelial cells

  Katri Lindfors (Examiner)

  2012 → …

  Activity: Evaluation, examination and supervision › Supervisor of master student

• Cellular and Molecular Immunology (Journal)

  Katri Lindfors (Reviewer)

  2012

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Journal of Cellular and Molecular Medicine (Journal)

  Katri Lindfors (Reviewer)

  2012

  Activity: Publication peer-review and editorial work › Reviewer of Scientific Journal

• Injection of coeliac patient serum or immunoglobulins to mice reproduces a condition mimicking early developing coeliac disease

  Suvi Kalliokoski (Contributor), Sergio Caja Galan (Contributor), Katri Kaukinen (Contributor), Ilma Korponay-Szabó (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation

• The effects of TG2 inhibitors on gliadin-induced toxicity: Implications for future coeliac disease therapy

  Tiina Rauhavirta (Contributor), Katri Kaukinen (Contributor), Katri Lindfors (Contributor) & Markku Mäki (Contributor)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation

• Coeliac disease-specific autoantibodies targeted against transglutaminase 2 disturb vessel morphogenesis in vitro and in vivo through RhoB

  Suvi Kallikoski (Speaker), Cristina Nadalluti (Speaker), Tina Rauhavista (Speaker), Ana-Marija Sulic (Speaker), Markku Mäki (Speaker), Katri Kaukinen (Speaker) & Katri Lindfors (Speaker)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation

• Chemokine receptor CCR9 and its ligand CCL25 in coeliac disease

  Laura Airaksinen (Contributor), Katri Kaukinen (Contributor), Johanna Schleutker (Contributor), Päivi Saavalainen (Contributor), Markku Mäki (Contributor) & Katri Lindfors (Contributor)

  15 Dec 2011

  Activity: Talk or presentation › Conference presentation